Bruker (BRKR) Tops Q1 EPS by 7c

Bruker (NASDAQ: BRKR) reported Q1 EPS of $0.49, $0.07 better than the analyst estimate of $0.42. Revenue for the quarter came in at $595 million versus the consensus estimate of $572.57 million.

GUIDANCE:

Bruker sees FY2022 EPS of $2.29-$2.33, versus the consensus of $2.29.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c